Voglihal MD 0.3 Tablet
Marketer
Halden Healthcare & Research Pvt Ltd
Salt Composition
Voglibose (0.3mg)
Overview Voglihal MD 0.3 Tablet
Diabetic patients with type 2 mellitus may find relief with the 0.3mg Voglihal MD tablet. This medication assists in post-prandial blood glucose regulation, employed when dietary changes and other comparable treatments prove insufficient. Administer Voglihal MD 0.3mg immediately prior to meals; dosage and frequency should be determined by your physician for optimal glycemic control. Abrupt cessation is strongly discouraged; discontinuation without medical consultation may lead to dangerously elevated blood sugar, risking severe complications such as renal impairment and vision loss. This medication forms one element of a comprehensive diabetes management plan, encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential. Commonly reported side effects include abdominal discomfort, flatulence, appetite suppression, bowel irregularity, and diarrhea. Persistent or troublesome side effects warrant immediate medical attention. While Voglihal MD 0.3mg alone doesn't typically induce hypoglycemia, concurrent use with other anti-diabetic medications (particularly insulin or sulfonylureas) increases this risk. Treat hypoglycemic episodes with plain glucose; sucrose is ineffective in this context. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, or gastrointestinal issues such as ulcerative colitis or Crohn's disease, as these may contraindicate use. Pregnant or lactating individuals should seek medical advice before using this medication. Full disclosure of all other medications is crucial for safe usage. Limit alcohol consumption, as it can heighten the risk of hypoglycemia.
Primary Ingredients of Voglihal MD 0.3 Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Voglihal MD 0.3 Tablet
Managing Type 2 Diabetes
Major Benefits of Voglihal MD 0.3 Tablet:
Administer Voglihal MD 0.3 Tablet as prescribed by your physician. Avoid handling the tablets with damp hands. Place the tablet in your mouth, allowing it to dissolve before swallowing. This medication should be taken on an empty stomach.
Common Side effects of Voglihal MD 0.3 Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voglihal MD 0.3 Tablet:
Administer Voglihal MD 0.3 Tablet as directed by your physician. Avoid contact with moisture when handling the tablets. Place the tablet in your mouth, allowing it to dissolve before swallowing. This medication should be taken on an empty stomach.
How Voglihal MD 0.3 Tablet works:
Voglihal MD 0.3mg tablets are used to manage diabetes. Their mechanism involves blocking the action of enzymes in the intestines that digest complex carbohydrates into simple sugars like glucose, thus moderating post-meal blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Voglihal MD 0.3 Tablet is inadvisable.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Voglihal MD 0.3 Tablet is generally deemed safe. Preclinical trials in animals revealed minimal or no harm to offspring; however, data from human studies remains scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Voglihal MD 0.3 Tablet safely. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Voglihal MD 0.3 Tablet.
KidneyCAUTION
Patients with severe kidney impairment should use Voglihal MD 0.3 Tablet cautiously, as dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Voglihal MD 0.3 Tablet cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Voglihal MD 0.3 Tablet :
Omit any missed Voglihal MD 0.3 Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Voglihal MD 0.3 Tablet
| Label | Value |
|---|---|
| Chemical Category | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Alpha-glucosidase inhibitors |


